Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
331. |
ECCT/20/09/04 | Pharmacy PrEP Delivery Pharmacy delivery to expand the reach of PrEP in Kenya: Pilot Study |
Principal Investigator(s) 1. Prof. Elizabeth Bukusi Site(s) in Kenya 1. PHRDTHIKA (Kiambu county) 2. Kisumu Site (Kisumu county) |
27-10-2020 |
View |
332. |
ECCT/20/09/02 | BEe-HIVe B-ENHANCEMENT OF HBV VACCINATIONIN PERSONS LIVING WITH HIV (BEe-HIVe) EVALUATION OF HEPLISAV-B,A5379 |
Principal Investigator(s) 1. JOSPHAT KOSGEI Site(s) in Kenya KEMRI/KERICHO CLINIC RESEARCH CENTRE |
27-11-2020 |
View |
333. |
ECCT/20/09/01 | PrEP in Pharmacy - PILOT STUDY Pharmacy delivery to expand the reach of PrEP in Kenya: Pilot study |
Principal Investigator(s) 1. Kenneth Kairu Ngure Site(s) in Kenya KEMRI-CCR PHRD (THIKA) PROJECT |
28-10-2020 |
View |
334. |
ECCT/20/08/04 | LOW DOSE RADIATION THERAPY A pilot phase Ib/II study of whole-lung low dose radiation therapy (LDRT) in the treatment of severe Covid 19 pneumonia patients on (or requiring) mechanical ventilatory support |
Principal Investigator(s) 1. PROF. MANSOOR SALEH Site(s) in Kenya Aga Khan University Hospital, Nairobi |
11-11-2020 |
View |
335. |
ECCT/20/08/03 | NIH_PREFER Prebiotic galacto-oligosaccharides and lactoferrin for beneficial gut microbiota with iron supplements: an intervention trial in infants in Msambweni, Kwale County, southern coastal Kenya |
Principal Investigator(s) 1. Gary Brittenham Site(s) in Kenya Msambweni County Referral Hospital |
21-02-2021 |
View |
336. |
ECCT/20/08/02 | ALIVE study Evaluation of the effectiveness of IVERMECTIN co-formulation vs ALBENDAZOLE for treatment of for the Treatment of Soil-Transmitted Helminth Infections (Trichuris trichiura, hookworm, Strongyloides stercoralis) in school aged children and Young Adult Subjects (ALIVE Study) |
Principal Investigator(s) 1. Charles Mwandawiro Site(s) in Kenya Kwale |
12-01-2021 |
View |
337. |
ECCT/20/08/01 | CorNeat EverPatch The CorNeat EverPatch – A First-In-Human Clinical Study for Demonstrating the Safety of a Synthetic Tissue Substitute for Concealment of Artificial Implants and Glaucoma Tube Shunts |
Principal Investigator(s) 1. Lily Adhiambo Nyamai Site(s) in Kenya 1. Lions SightFirst Hospital (Nairobi City county) 2. Kenyatta National Hospital (Nairobi City county) 3. Kwale Eye Centre (Kwale county) |
10-11-2020 |
View |
338. |
ECCT/20/07/03 | STAND A Phase III multicenter, randomized, double blind study to assess efficacy and safety of two doses of crizanlizumab verses placebo, with or without hydroxyurea/hydroxycarbamide therapy in adolescent and adult sickle cell disease patients with Vaso-Occlusive Crises (STAND) |
Principal Investigator(s) 1. Bernhards Ragama Ogutu Site(s) in Kenya 1. CREATES Strathmore University (Nairobi City county) 2. Getrudes Childrens Hospital (Nairobi City county) 3. International Cancer Institute (Elgeyo/Marakwet county) |
30-11-2020 |
View |
339. |
ECCT/20/07/02 | RV 460 HIV Vaccine Trial A Randomized, Double-Blind Phase 1 Trial to Evaluate the Safety and Immunogenicity of Priming with Env-C Plasmid DNA Vaccine Alone, with Different Adjuvants, or with an Adjuvanted HIV Env gp145 C.6980 Protein Vaccine and Boosting with the Adjuvanted HIV Env gp145 C.6980 Protein Vaccine with or without the Env-C Plasmid DNA Vaccine in Healthy HIV Uninfected Adults in Kenya |
Principal Investigator(s) 1. Josphat Kosgei Site(s) in Kenya KEMRI/US MRDA-A/K, KERICHO |
19-10-2020 |
View |
340. |
ECCT/20/07/01 | Convalescent plasma trial A randomized control trial comparing convalescent plasma therapy plus standard treatment versus standard treatment alone in patients with severe COVID-19 pneumonia at a tertiary hospital |
Principal Investigator(s) 1. Dr Isaac Adembesa Kadambi Site(s) in Kenya Kenyatta University Teaching Referral and Research Hospital |
25-09-2020 |
View |